World's Best Scientists 2026 revealed!
Sandra Hervas-Stubbs

Sandra Hervas-Stubbs

D-Index & Metrics

Immunology

D-Index
46
Citations
10660
World Ranking
4589
National Ranking
55

Sandra Hervas-Stubbs publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sandra Hervas-Stubbs sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 165 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sandra Hervas-Stubbs D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sandra Hervas-Stubbs sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Sandra Hervas-Stubbs is affiliated with the University of Navarra in Spain. Their research primarily focuses on the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Within these areas, their work covers several subfields including Immunology, Oncology, Molecular Biology, Genetics, and Radiology, Nuclear Medicine and Imaging.

The scientist's research topics include:

  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Virus-based gene therapy research
  • Monoclonal and Polyclonal Antibodies Research
  • Hepatocellular Carcinoma Treatment and Prognosis

Sandra Hervas-Stubbs has contributed to several research papers, notably:

  • "Advances in immunotherapy for hepatocellular carcinoma," 2021, published in Nature Reviews Gastroenterology & Hepatology
  • "Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma," 2022, published in New England Journal of Medicine
  • "Microglia and astrocyte activation is region-dependent in the α-synuclein mouse model of Parkinson's disease," 2022, published in Glia
  • "Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants," 2021, published in Journal for ImmunoTherapy of Cancer
  • "CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models," 2021, published in Journal for ImmunoTherapy of Cancer

Their frequent co-authors include:

  • Juan José Lasarte (17 collaborations)
  • Pablo Sarobe (14 collaborations)
  • Ibón Tamayo (12 collaborations)
  • Noëlia Casares (12 collaborations)
  • Enrique Conde (9 collaborations)

Key publication venues for Sandra Hervas-Stubbs are:

  • Journal for ImmunoTherapy of Cancer (7 publications)
  • Journal of Hepatology (3 publications)
  • International Journal of Molecular Sciences (2 publications)
  • Frontiers in Immunology (2 publications)
  • IBRO Neuroscience Reports (2 publications)

Best Publications

  • Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

    Noelia Casares;Marie O. Pequignot;Antoine Tesniere;François Ghiringhelli

  • Advances in immunotherapy for hepatocellular carcinoma

    Bruno Sangro;Pablo Sarobe;Sandra Hervás-Stubbs;Ignacio Melero

  • Immunostimulatory monoclonal antibodies for cancer therapy

    Ignatio Melero;Sandra Hervas-Stubbs;Martin Glennie;Drew M. Pardoll

  • Direct Effects of Type I Interferons on Cells of the Immune System

    Sandra Hervas-Stubbs;Jose Luis Perez-Gracia;Ana Rouzaut;Miguel Fernandez de Sanmamed

  • Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense

    Johan Garaude;Rebeca Acín-Pérez;Sarai Martínez-Cano;Michel Enamorado

  • High‐yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts

    Andrea Molina;Sandra Hervás-Stubbs;Henry Daniell;Angel M. Mingo-Castel

  • Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes

    C Alfaro;N Suarez;A Gonzalez;S Solano

  • Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN

    Sandra Hervas-Stubbs;Paloma Rueda;Lissette Lopez;Claude Leclerc;Claude Leclerc

  • The HIF-1α Hypoxia Response in Tumor-Infiltrating T Lymphocytes Induces Functional CD137 (4-1BB) for Immunotherapy

    Asís Palazón;Iván Martínez-Forero;Alvaro Teijeira;Aizea Morales-Kastresana

  • Agonist Anti-CD137 mAb Act on Tumor Endothelial Cells to Enhance Recruitment of Activated T Lymphocytes

    Asís Palazón;Alvaro Teijeira;Iván Martínez-Forero;Sandra Hervás-Stubbs

  • Expansion of Tumor-Infiltrating CD8+ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy.

    Sarita M. Fernandez-Poma;Diego Salas-Benito;Teresa Lozano;Noelia Casares

  • Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ

    Juan Dubrot;Francisca Milheiro;Carlos Alfaro;Asis Palazón

  • Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic.

    Alicia Fernández-San Millán;Susana M. Ortigosa;Sandra Hervás-Stubbs;Patricia Corral-Martínez

  • Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice

    Manuela Gonzalez-Aparicio;Pilar Alzuguren;Itsaso Mauleon;Jose Medina-Echeverz

  • Combined Immunostimulatory Monoclonal Antibodies Extend Survival in an Aggressive Transgenic Hepatocellular Carcinoma Mouse Model

    Aizea Morales-Kastresana;Miguel F. Sanmamed;Inmaculada Rodriguez;Asis Palazon

  • High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.

    Sandra Hervas-Stubbs;Sandra Hervas-Stubbs;Laleh Majlessi;Laleh Majlessi;Marcela Simsova;Jana Morova

  • The Extra Domain A from Fibronectin Targets Antigens to TLR4-Expressing Cells and Induces Cytotoxic T Cell Responses In Vivo

    Juan J. Lasarte;Noelia Casares;Marta Gorraiz;Sandra Hervás-Stubbs;Sandra Hervás-Stubbs

  • Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells

    Iñaki Etxeberria;Elixabet Bolaños;Jose I. Quetglas;Alena Gros

  • Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies

    Ignacio Melero;Oihana Murillo;Juan Dubrot;Sandra Hervás-Stubbs

  • Effects of IFN-α as a signal-3 cytokine on human naïve and antigen-experienced CD8(+) T cells.

    Sandra Hervas-Stubbs;Jose-Ignacio Riezu-Boj;Iranzu Gonzalez;Uxua Mancheño

Frequent Co-Authors

Ignacio Melero
Ignacio Melero University of Oxford
Jesús Prieto
Jesús Prieto University of Navarra
Juan José Lasarte
Juan José Lasarte University of Navarra
Bruno Sangro
Bruno Sangro University of Navarra
Plácido Navas
Plácido Navas Pablo de Olavide University
José Antonio Enríquez
José Antonio Enríquez Spanish National Centre for Cardiovascular Research
José L. Carrascosa
José L. Carrascosa Spanish National Research Council
Lieping Chen
Lieping Chen Yale University
Peter Sebo
Peter Sebo Czech Academy of Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can open up diverse career opportunities. Many students consider online nursing degrees to complement their expertise, especially programs designed for those without prior nursing experience. The online nursing programs for non nurses provide flexible options to enter the nursing profession, leveraging foundational healthcare knowledge useful in immunology.

Accelerated nursing programs offer a fast track to becoming a registered nurse, which can be an ideal bridge for immunology students seeking clinical experience. These programs are known for their rigorous pace, yet they are tailored to help students transition quickly. Check out the accelerated nursing programs for accessible pathways with streamlined admissions.

For those aiming for practical nursing roles, Licensed Practical Nurse (LPN) programs present a valuable option. Understanding which lpn programs are easiest to get into can help prospective students find less competitive gateways into the nursing field while gaining hands-on clinical skills relevant to immunology and patient care.

Advancing your career further might involve pursuing nurse practitioner degrees focused on family practice or pediatrics. The easiest fnp program listings guide future nurse practitioners toward programs with more accessible admissions, ensuring that healthcare professionals with immunology backgrounds can advance into specialized, patient-centered roles efficiently.

Best Scientists Citing Sandra Hervas-Stubbs

Trending Scientists

Recently Published Articles